ATOSSA THERAPEUTICS, INC. 8-K

What Happened
Atossa Therapeutics, Inc. announced its fourth quarter and full‑year financial results for the period ended December 31, 2025 and issued a company update via a press release dated March 25, 2026. The company filed a Current Report on Form 8‑K (Items 2.02 and 9.01) to disclose the release and attached the press release as Exhibit 99.1.

Key Details

• Date of announcement: March 25, 2026.
• Period covered: fourth quarter and year ended December 31, 2025.
• The press release detailing results and the company update is attached as Exhibit 99.1 to the 8‑K.
• The company states the information in Items 2.02 and 9.01 (and Exhibit 99.1) is furnished, not “filed,” and therefore is not subject to certain liabilities under the Securities Exchange Act or the Securities Act.

Why It Matters
This filing delivers Atossa’s most recent earnings and operational update to investors and the market. Retail investors should read the attached press release (Exhibit 99.1) for specific financial figures, guidance, or operational developments that could affect the company’s outlook or stock performance. The 8‑K clarifies the regulatory status of the release (furnished vs. filed), which affects how the information is treated under securities laws.